日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rickettsia akari NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP422645RIL
CSB-EP422645RIL
CSB-BP422645RIL
CSB-MP422645RIL
CSB-EP422645RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Putative adhesin A1C_06425 (A1C_06425) CSB-YP422646RIL
CSB-EP422646RIL
CSB-BP422646RIL
CSB-MP422646RIL
CSB-EP422646RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari Trigger factor (tig) CSB-YP422647RIL
CSB-EP422647RIL
CSB-BP422647RIL
CSB-MP422647RIL
CSB-EP422647RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia akari 30S ribosomal protein S16 (rpsP) CSB-YP422648RIL
CSB-EP422648RIL
CSB-BP422648RIL
CSB-MP422648RIL
CSB-EP422648RIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii DNA replication and repair protein recF (recF) CSB-YP422649RNC
CSB-EP422649RNC
CSB-BP422649RNC
CSB-MP422649RNC
CSB-EP422649RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii tRNA (Ile)-lysidine synthase CSB-YP422650RNC
CSB-EP422650RNC
CSB-BP422650RNC
CSB-MP422650RNC
CSB-EP422650RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Deoxycytidine triphosphate deaminase (dcd) CSB-YP422651RNC
CSB-EP422651RNC
CSB-BP422651RNC
CSB-MP422651RNC
CSB-EP422651RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 30S ribosomal protein S2 (rpsB) CSB-YP422652RNC
CSB-EP422652RNC
CSB-BP422652RNC
CSB-MP422652RNC
CSB-EP422652RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 50S ribosomal protein L19 (rplS) CSB-YP422653RNC
CSB-EP422653RNC
CSB-BP422653RNC
CSB-MP422653RNC
CSB-EP422653RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP422654RNC
CSB-EP422654RNC
CSB-BP422654RNC
CSB-MP422654RNC
CSB-EP422654RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Dihydrodipicolinate reductase (dapB) CSB-YP422655RNC
CSB-EP422655RNC
CSB-BP422655RNC
CSB-MP422655RNC
CSB-EP422655RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (dapD) CSB-YP422656RNC
CSB-EP422656RNC
CSB-BP422656RNC
CSB-MP422656RNC
CSB-EP422656RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 30S ribosomal protein S9 (rpsI) CSB-YP422657RNC
CSB-EP422657RNC
CSB-BP422657RNC
CSB-MP422657RNC
CSB-EP422657RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii UDP-N-acetylmuramate--L-alanine ligase (murC) CSB-YP422658RNC
CSB-EP422658RNC
CSB-BP422658RNC
CSB-MP422658RNC
CSB-EP422658RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii DNA mismatch repair protein MutS (mutS), partial CSB-YP422659RNC
CSB-EP422659RNC
CSB-BP422659RNC
CSB-MP422659RNC
CSB-EP422659RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii 30S ribosomal protein S4 (rpsD) CSB-YP422660RNC
CSB-EP422660RNC
CSB-BP422660RNC
CSB-MP422660RNC
CSB-EP422660RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP422661RNC
CSB-EP422661RNC
CSB-BP422661RNC
CSB-MP422661RNC
CSB-EP422661RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Leucine--tRNA ligase (leuS), partial CSB-YP422662RNC
CSB-EP422662RNC
CSB-BP422662RNC
CSB-MP422662RNC
CSB-EP422662RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP422663RNC
CSB-EP422663RNC
CSB-BP422663RNC
CSB-MP422663RNC
CSB-EP422663RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rickettsia rickettsii Probable transcriptional regulatory protein A1G_04400 (A1G_04400) CSB-YP422664RNC
CSB-EP422664RNC
CSB-BP422664RNC
CSB-MP422664RNC
CSB-EP422664RNC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×